Serial Number
90494961
Owner
OncoCyte CorporationAttorney
Christopher D. Olszyk, Jr.Filing Date
Jan 28, 2021
DETERMACNI Trademark
Serial Number: 90494961
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 10 - Medical Apparatus
Surgical, medical, dental and veterinary apparatus and instruments
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
Legal Representation
Correspondence Address
Christopher D. Olszyk, Jr. FOX ROTHSCHILD LLP
212 Carnegie Center, Suite 400
Princeton, NJ 08540
United States
Trademark Details
Filing Date
January 28, 2021
Registration Date
Not Registered
Published for Opposition
April 19, 2022
Goods & Services
Chemical reagents for medical or veterinary purposes; clinical medical reagents; diagnostic reagents for medicinal use; medical diagnostic reagents; reagents for medical use
Diagnostic reagents for clinical or medical laboratory use; diagnostic reagents for scientific or research use; reagents for scientific or medical research use
Medical services, namely, providing blood testing and diagnostic services for others in the field of cancer testing, tumor testing, and screening for the purpose of monitoring patients post-treatment for the probability of cancer reoccurrence
Biopsy tests and devices, namely, medical instruments for use in performing blood-based testing and medical diagnostic apparatus for testing changes in biomarkers; cancer screening tests and devices, namely, medical devices for post-cancer treatment reoccurrence monitoring; medical diagnostic apparatus for testing patients' post-cancer treatment biomarkers
Providing blood reagent sample testing and diagnostic services for others in the field of cancer testing, tumor testing, and screening for the purpose of monitoring patients post-treatment for the probability of cancer reoccurrence
